|
US5175343A
(en)
|
1985-01-14 |
1992-12-29 |
Neorx Corporation |
Metal radionuclide labeled proteins for diagnosis and therapy
|
|
US4889931A
(en)
|
1988-09-27 |
1989-12-26 |
Salutar, Inc. |
Manganese (II) chelate manufacture
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE69024826T2
(de)
|
1989-02-10 |
1996-06-27 |
Celltech Therapeutics Ltd |
Aza-Macrozyklen und Verfahren zu deren Herstellung
|
|
US5053503A
(en)
*
|
1989-02-17 |
1991-10-01 |
Centocor |
Chelating agents
|
|
US5364613A
(en)
|
1989-04-07 |
1994-11-15 |
Sieving Paul F |
Polychelants containing macrocyclic chelant moieties
|
|
US6274713B1
(en)
|
1989-04-07 |
2001-08-14 |
Salutar, Inc. |
Polychelants
|
|
US7385041B2
(en)
|
1990-04-25 |
2008-06-10 |
Bracco International B.V. |
Dual functioning excipient for metal chelate contrast agents
|
|
AU648315B2
(en)
|
1990-06-18 |
1994-04-21 |
Dow Chemical Company, The |
The use of macrocyclic aminophosphonic acid complexes as imaging agents
|
|
US5386011A
(en)
|
1990-12-27 |
1995-01-31 |
Abbott Laboratories |
Hexapeptide anaphylatoxin-receptor ligands
|
|
GB9112536D0
(en)
*
|
1991-06-11 |
1991-07-31 |
Celltech Ltd |
Chemical compounds
|
|
WO1992022324A1
(en)
|
1991-06-14 |
1992-12-23 |
Xoma Corporation |
Microbially-produced antibody fragments and their conjugates
|
|
EP0646019B9
(en)
|
1992-06-09 |
2002-12-18 |
Neorx Corporation |
Biotin-DOTA conjugates and their use in pretargeting methods
|
|
US5358704A
(en)
|
1993-09-30 |
1994-10-25 |
Bristol-Myers Squibb |
Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents
|
|
GB9504922D0
(en)
|
1995-03-10 |
1995-04-26 |
Nycomed As |
Process
|
|
US8951499B2
(en)
*
|
1996-02-08 |
2015-02-10 |
University Of Washington |
Trifunctional reagent for conjugation to a biomolecule
|
|
BRPI9809391B8
(pt)
|
1997-04-14 |
2021-05-25 |
Amgen Res Munich Gmbh |
processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica
|
|
IT1291624B1
(it)
|
1997-04-18 |
1999-01-11 |
Bracco Spa |
Chelati complessi di metalli paramagnetici a bassa tossicita'
|
|
IT1304501B1
(it)
|
1998-12-23 |
2001-03-19 |
Bracco Spa |
Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
|
|
JP2003501488A
(ja)
|
1999-06-11 |
2003-01-14 |
ネオルックス コーポレイション |
骨髄抑制のための高投与量放射性核種錯体
|
|
DE10002939C1
(de)
|
2000-01-13 |
2001-09-20 |
Schering Ag |
Paramagnetische DOTA-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für die Herstellung von pharmazeutischen Mitteln
|
|
US20020052354A1
(en)
|
2000-01-27 |
2002-05-02 |
Schering Ag |
Paramagnetic DOTA derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction
|
|
US6264966B1
(en)
|
2000-02-22 |
2001-07-24 |
Concat, Ltd. |
Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
|
|
WO2002024235A2
(en)
|
2000-05-12 |
2002-03-28 |
University Hospital |
Prochelators of radiometal labeled molecules
|
|
EP1390081A2
(en)
|
2001-01-08 |
2004-02-25 |
Neorx Corporation |
Therapeutic and diagnostic compounds, compositions, and methods
|
|
EP1385556A4
(en)
*
|
2001-05-02 |
2005-10-19 |
Univ Missouri System At Columb |
PEPTIDE CONJUGATES WITH AFFINITY FOR GASTRIN RECEPTORS
|
|
DE10135355C1
(de)
|
2001-07-20 |
2003-04-17 |
Schering Ag |
Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie
|
|
DE10135356C1
(de)
|
2001-07-20 |
2003-04-17 |
Schering Ag |
Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
|
|
TWI240632B
(en)
|
2001-07-30 |
2005-10-01 |
Epix Medical Inc |
Purified peptides for peptide-based multimeric targeted contrast agents
|
|
EP1542709A2
(en)
|
2002-08-06 |
2005-06-22 |
EPIX Pharmaceuticals, Inc. |
Peptide aggregates
|
|
DE10250870A1
(de)
|
2002-10-31 |
2004-05-13 |
Switch Biotech Ag |
Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung
|
|
US20060235296A1
(en)
|
2003-02-13 |
2006-10-19 |
Bracco Imaging S.P.A. |
Contrast enhanced x-ray phase imaging
|
|
NZ542371A
(en)
|
2003-03-19 |
2008-10-31 |
Universitatsspital Basel |
Radiolabeled conjugates based on substance P and the uses thereof
|
|
WO2005001415A2
(en)
|
2003-05-23 |
2005-01-06 |
Epix Pharmaceuticals, Inc. |
Optically pure and enriched isomers of chelating ligands and contrast agents
|
|
JP4262545B2
(ja)
|
2003-07-09 |
2009-05-13 |
三菱電機株式会社 |
カスコード接続回路及びその集積回路
|
|
JP5139678B2
(ja)
*
|
2003-07-24 |
2013-02-06 |
ブラッコ・イメージング・ソシエタ・ペル・アチオニ |
安定な放射性医薬品組成物およびその製法
|
|
US20050064485A1
(en)
|
2003-09-12 |
2005-03-24 |
Kurt Vogel |
Multiplex binding and activity assays
|
|
CA2550071A1
(en)
|
2003-12-19 |
2005-07-07 |
Schering Corporation |
Pharmaceutical compositions
|
|
WO2005079803A1
(en)
|
2004-02-13 |
2005-09-01 |
Pfizer Products, Inc. |
Compounds for treatment of cardiovascular diseases
|
|
WO2006015318A2
(en)
|
2004-07-30 |
2006-02-09 |
Biogen Idec Inc. |
Antibody conjugated to a drug moiety via a poptidic linker
|
|
DK1791565T3
(en)
|
2004-09-23 |
2016-08-01 |
Genentech Inc |
Cysteingensplejsede antibodies and conjugates
|
|
US20060222595A1
(en)
|
2005-03-31 |
2006-10-05 |
Priyabrata Mukherjee |
Nanoparticles for therapeutic and diagnostic applications
|
|
WO2007009637A2
(de)
|
2005-07-15 |
2007-01-25 |
Bayer Schering Pharma Aktiengesellschaft |
Deren verwendung als kontrastmittel zur anwendung in der nmr-, rontgen- und radiodiagnostik sowie in der radiotheraphie
|
|
US7618957B2
(en)
|
2005-07-15 |
2009-11-17 |
Bayer Schering Pharma Aktiengesellschaft |
Perfluoroalkyl-containing complexes, process for their production as well as their use
|
|
US20100226884A1
(en)
|
2009-01-20 |
2010-09-09 |
Immunomedics, Inc. |
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)
|
|
US8034898B2
(en)
|
2005-12-29 |
2011-10-11 |
Collagen Medical, LLC |
Methods of collagen imaging
|
|
EP1993613A2
(en)
|
2006-03-15 |
2008-11-26 |
Mallinckrodt, Inc. |
Chelating conjugates having a substituted aromatic moiety and derivatives thereof
|
|
AU2007245164A1
(en)
*
|
2006-03-28 |
2007-11-08 |
Biogen Idec Ma Inc. |
Anti-IGF-IR antibodies and uses thereof
|
|
US7777029B2
(en)
|
2006-05-02 |
2010-08-17 |
San Diego State University (Sdsu) Foundation |
Bifunctional chelators for sequestering lanthanides
|
|
EP2061884A4
(en)
|
2006-08-11 |
2010-03-24 |
Life Technologies Corp |
SENSOR PROTEINS AND TEST PROCEDURES THEREFOR
|
|
US8691761B2
(en)
|
2006-10-16 |
2014-04-08 |
Jean E. F. Rivier |
Somatostatin receptor 2 antagonists
|
|
GB0624587D0
(en)
*
|
2006-12-08 |
2007-01-17 |
Univ Muenchen Tech |
Chelating agent
|
|
EP2114461A2
(en)
|
2007-01-19 |
2009-11-11 |
Mallinckrodt Inc. |
Diagnostic and therapeutic cyclooxygenase-2 binding ligands
|
|
WO2008134289A2
(en)
|
2007-04-26 |
2008-11-06 |
Mallinckrodt Inc. |
High relaxivity coordinatively unsaturated lanthanide complexes
|
|
US8420857B2
(en)
|
2007-08-27 |
2013-04-16 |
Mallinckrodt Llc |
Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography
|
|
CA2697612A1
(en)
*
|
2007-08-28 |
2009-03-12 |
Biogen Idec Ma Inc. |
Anti-igf-1r antibodies and uses thereof
|
|
US20090208421A1
(en)
|
2008-02-19 |
2009-08-20 |
Dominique Meyer |
Process for preparing a pharmaceutical formulation of contrast agents
|
|
EP2100900A1
(en)
*
|
2008-03-07 |
2009-09-16 |
Universitätsspital Basel |
Bombesin analog peptide antagonist conjugates
|
|
DE102008045937B4
(de)
|
2008-04-11 |
2017-01-26 |
Johannes-Gutenberg-Universität Mainz |
Radiopharmakon aus einem Metallion und einem Markierungsvorläufer und Verwendung des Radiopharmakons
|
|
CN102065895A
(zh)
*
|
2008-04-11 |
2011-05-18 |
比奥根艾迪克Ma公司 |
抗-igf-1r抗体和其它化合物的治疗联合
|
|
WO2010009246A2
(en)
|
2008-07-16 |
2010-01-21 |
The General Hospital Corporation |
Methods and reagents for preparing multifunctional probes
|
|
EP2147684A1
(en)
|
2008-07-22 |
2010-01-27 |
Bracco Imaging S.p.A |
Diagnostic Agents Selective Against Metalloproteases
|
|
EP2362784A2
(en)
|
2008-11-06 |
2011-09-07 |
Luisa Bracci |
Neurotensin-derived branched peptides and uses thereof
|
|
WO2010088527A2
(en)
|
2009-01-30 |
2010-08-05 |
Mayo Foundation For Medical Education And Research |
Peptides and nanoparticles for therapeutic and diagnostic applications
|
|
CN102356087A
(zh)
|
2009-03-19 |
2012-02-15 |
惠氏有限责任公司 |
[2-(8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1(7)-烯-2-基)乙基]膦酸及其前体的制备方法
|
|
US9290577B2
(en)
*
|
2009-07-03 |
2016-03-22 |
Avipep Pty Limited |
Immuno-conjugates and methods for producing them
|
|
WO2011005609A2
(en)
|
2009-07-08 |
2011-01-13 |
Mayo Foundation For Medical Education And Research |
Imaging gastrointestinal volumes and motility
|
|
CA2785410A1
(en)
|
2009-12-23 |
2011-06-30 |
Carlos F. Barbas, Iii |
Tyrosine bioconjugation through aqueous ene-like reactions
|
|
WO2011090492A1
(en)
|
2010-01-19 |
2011-07-28 |
Immunomedics, Inc. |
Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
|
|
EP2397466B1
(en)
|
2010-06-15 |
2012-11-28 |
Centre National De La Recherche Scientifique CNRS |
X-ray and gamma-photon activatable organic compounds, their preparation and their uses
|
|
US9573978B2
(en)
|
2010-08-12 |
2017-02-21 |
S&T Global, Inc. |
Cyclosporin derivatives for the treatment and prevention of a viral infection
|
|
US9463256B2
(en)
*
|
2010-10-14 |
2016-10-11 |
Koninklijke Philips N.V. |
Pretargeting kit, method and agents used therein
|
|
US12097269B2
(en)
|
2010-10-27 |
2024-09-24 |
Vikas Kundra |
Dual mode gadolinium nanoparticle contrast agents
|
|
FR2968999B1
(fr)
|
2010-12-20 |
2013-01-04 |
Guerbet Sa |
Nanoemulsion de chelate pour irm
|
|
EP2673297A2
(en)
*
|
2011-02-11 |
2013-12-18 |
Zyngenia, Inc. |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
WO2012122420A2
(en)
|
2011-03-09 |
2012-09-13 |
Pharmacofore, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
PL2721045T3
(pl)
|
2011-06-20 |
2017-11-30 |
Radiomedix Inc. |
Kompozycie, metody syntezy i zastosowanie węglowodanowych środków ukierunkowanych
|
|
FR2976825B1
(fr)
|
2011-06-22 |
2014-02-21 |
Total Sa |
Nanotraceurs pour le marquage d'eaux d'injection de champs petroliers
|
|
EP2604281B1
(en)
|
2011-12-14 |
2014-07-30 |
Centre National de la Recherche Scientifique (CNRS) |
Clicked somatostatin conjugated analogs for biological applications
|
|
KR20130083592A
(ko)
|
2012-01-13 |
2013-07-23 |
현대약품 주식회사 |
치환된 피페리딘 유도체 및 이의 제조방법
|
|
US20150056191A1
(en)
*
|
2012-03-30 |
2015-02-26 |
Merck Sharp & Dohme Corp. |
Igf1 biomarker for igf1r inhibitor therapy
|
|
EP2861723A4
(en)
|
2012-06-14 |
2016-01-20 |
Janssen Biotech Inc |
DIFFERENTIATION OF HUMAN EMBRYONAL STEM CELLS IN ENDOCRINE PANCREAS CELLS
|
|
CN102743770B
(zh)
|
2012-06-18 |
2017-07-21 |
申宝忠 |
一种靶向性分子成像探针及活体分子成像方法
|
|
EP2892570B1
(en)
|
2012-09-07 |
2019-02-27 |
Bracco Imaging S.p.A |
Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri
|
|
US9931412B2
(en)
|
2013-02-08 |
2018-04-03 |
The Regents Of The University Of Michigan |
Targeted theranostics
|
|
WO2014180524A1
(en)
|
2013-05-06 |
2014-11-13 |
Merck Patent Gmbh |
Macrocycles as kinase inhibitors
|
|
US10786497B2
(en)
|
2013-08-16 |
2020-09-29 |
Equip, Llc |
Discrete PEG constructs
|
|
WO2015038968A1
(en)
|
2013-09-13 |
2015-03-19 |
The General Hospital Corporation |
Activatable fibrin-binding probes
|
|
EP3456700A1
(en)
|
2013-10-18 |
2019-03-20 |
Deutsches Krebsforschungszentrum |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
EP3068443B1
(en)
*
|
2013-11-12 |
2019-04-10 |
Centre for Probe Development and Commercialization |
Residualizing linkers and uses thereof
|
|
WO2015085005A1
(en)
|
2013-12-03 |
2015-06-11 |
The General Hospital Corporation |
Molecular imaging probes
|
|
FR3015547B1
(fr)
|
2013-12-20 |
2016-01-01 |
Total Sa |
Methode pour ajuster le taux d'inhibiteurs dans un puits de petrole ou de gaz
|
|
GB201403875D0
(en)
|
2014-03-05 |
2014-04-16 |
Cantargia Ab |
Novel antibodies and uses thereof
|
|
JP6685924B2
(ja)
|
2014-04-11 |
2020-04-22 |
メディミューン，エルエルシー |
システイン操作抗体を含むコンジュゲート化合物
|
|
PT3134127T
(pt)
|
2014-04-25 |
2020-04-09 |
Rinat Neuroscience Corp |
Conjugados de anticorpo-fármaco com alta carga de fármaco
|
|
US11660357B2
(en)
|
2014-05-16 |
2023-05-30 |
David A. Scheinberg |
One-step labeling of antibodies to high specific activity with actinium-225
|
|
WO2016016329A1
(en)
|
2014-07-29 |
2016-02-04 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
|
BE1021191B1
(fr)
|
2014-08-29 |
2015-10-27 |
Anmi S.A. |
Kit pour radiomarquage.
|
|
GB201417067D0
(en)
|
2014-09-26 |
2014-11-12 |
South African Nuclear Energy |
Radiopharmaceutical conjugate
|
|
DE102014115154A1
(de)
|
2014-10-17 |
2016-04-21 |
SCV-SpezialChemikalien-Vertrieb GmbH |
Konjugierte Bisphosphonate für die Diagnostik und Therapie von Knochenerkrankungen
|
|
CA2969067A1
(en)
|
2014-11-25 |
2016-06-02 |
Bristol-Myers Squibb Company |
Novel pd-l1 binding polypeptides for imaging
|
|
WO2017120193A1
(en)
|
2016-01-04 |
2017-07-13 |
University Of Kansas |
Drug delivery compositions and methods
|
|
WO2017161356A1
(en)
|
2016-03-18 |
2017-09-21 |
Wake Forest University |
Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
|
|
US10093741B1
(en)
*
|
2017-05-05 |
2018-10-09 |
Fusion Pharmaceuticals Inc. |
IGF-1R monoclonal antibodies and uses thereof
|
|
MA48861A
(fr)
*
|
2017-05-05 |
2020-04-01 |
Fusion Pharmaceuticals Inc |
Améliorations pharmacocinétiques de chélates bifonctionnels et leurs utilisations
|
|
WO2018204872A2
(en)
*
|
2017-05-05 |
2018-11-08 |
Fusion Pharmaceuticals Inc. |
Igf-1r monoclonal antibodies and uses thereof
|
|
CA3190855A1
(en)
*
|
2020-08-27 |
2022-03-03 |
Joe Mccann |
Radiopharmaceutical and methods
|
|
AU2022397307A1
(en)
*
|
2021-11-26 |
2024-06-06 |
Full-Life Technologies Uk Limited |
Cleavable radioligands for targeting cell surface receptors and uses thereof
|